185 related articles for article (PubMed ID: 27855170)
21. Cancer survival classification using integrated data sets and intermediate information.
Kim S; Park T; Kon M
Artif Intell Med; 2014 Sep; 62(1):23-31. PubMed ID: 24997860
[TBL] [Abstract][Full Text] [Related]
22. Cancer Subtype Discovery Using Prognosis-Enhanced Neural Network Classifier in Multigenomic Data.
Vasudevan P; Murugesan T
Technol Cancer Res Treat; 2018 Jan; 17():1533033818790509. PubMed ID: 30092720
[TBL] [Abstract][Full Text] [Related]
23. A 6-Gene Risk Signature Predicts Survival of Glioblastoma Multiforme.
Zhao J; Wang L; Hu G; Wei B
Biomed Res Int; 2019; 2019():1649423. PubMed ID: 31531345
[TBL] [Abstract][Full Text] [Related]
24. RNA-Sequencing Analysis Pipeline for Prognostic Marker Identification in Cancer.
Shukla S; Khadirnaikar S
Methods Mol Biol; 2021; 2174():119-131. PubMed ID: 32813247
[TBL] [Abstract][Full Text] [Related]
25. Bayesian variable selection with graphical structure learning: Applications in integrative genomics.
Kundu S; Cheng Y; Shin M; Manyam G; Mallick BK; Baladandayuthapani V
PLoS One; 2018; 13(7):e0195070. PubMed ID: 30059495
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous miRNA and mRNA transcriptome profiling of glioblastoma samples reveals a novel set of OncomiR candidates and their target genes.
Gulluoglu S; Tuysuz EC; Sahin M; Kuskucu A; Kaan Yaltirik C; Ture U; Kucukkaraduman B; Akbar MW; Gure AO; Bayrak OF; Dalan AB
Brain Res; 2018 Dec; 1700():199-210. PubMed ID: 30176243
[TBL] [Abstract][Full Text] [Related]
27. Molecular classification of IDH-mutant glioblastomas based on gene expression profiles.
Wu F; Chai RC; Wang Z; Liu YQ; Zhao Z; Li GZ; Jiang HY
Carcinogenesis; 2019 Jul; 40(7):853-860. PubMed ID: 30877769
[TBL] [Abstract][Full Text] [Related]
28. Development of robust discriminant equations for assessing subtypes of glioblastoma biopsies.
Castells X; Acebes JJ; Majós C; Boluda S; Julià-Sapé M; Candiota AP; Ariño J; Barceló A; Arús C
Br J Cancer; 2012 May; 106(11):1816-25. PubMed ID: 22568967
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA expression signatures and their correlation with clinicopathological features in glioblastoma multiforme.
Henriksen M; Johnsen KB; Olesen P; Pilgaard L; Duroux M
Neuromolecular Med; 2014 Sep; 16(3):565-77. PubMed ID: 24817689
[TBL] [Abstract][Full Text] [Related]
30. The N
Zhao R; Li B; Zhang S; He Z; Pan Z; Guo Q; Qiu W; Qi Y; Zhao S; Wang S; Chen Z; Zhang P; Guo X; Xue H; Li G
Front Immunol; 2021; 12():653711. PubMed ID: 34354698
[TBL] [Abstract][Full Text] [Related]
31. Genetic and clinical characteristics of primary and secondary glioblastoma is associated with differential molecular subtype distribution.
Li R; Li H; Yan W; Yang P; Bao Z; Zhang C; Jiang T; You Y
Oncotarget; 2015 Mar; 6(9):7318-24. PubMed ID: 25821160
[TBL] [Abstract][Full Text] [Related]
32. A 4-miRNAs signature predicts survival in glioblastoma multiforme patients.
Yuan GQ; Wei NL; Mu LY; Wang XQ; Zhang YN; Zhou WN; Pan YW
Cancer Biomark; 2017 Dec; 20(4):443-452. PubMed ID: 28869437
[TBL] [Abstract][Full Text] [Related]
33. Developing the novel bioinformatics algorithms to systematically investigate the connections among survival time, key genes and proteins for Glioblastoma multiforme.
You Y; Ru X; Lei W; Li T; Xiao M; Zheng H; Chen Y; Zhang L
BMC Bioinformatics; 2020 Sep; 21(Suppl 13):383. PubMed ID: 32938364
[TBL] [Abstract][Full Text] [Related]
34. A 4-miRNA signature predicts the therapeutic outcome of glioblastoma.
Niyazi M; Pitea A; Mittelbronn M; Steinbach J; Sticht C; Zehentmayr F; Piehlmaier D; Zitzelsberger H; Ganswindt U; Rödel C; Lauber K; Belka C; Unger K
Oncotarget; 2016 Jul; 7(29):45764-45775. PubMed ID: 27302927
[TBL] [Abstract][Full Text] [Related]
35. Using evolutional properties of gene networks in understanding survival prognosis of glioblastoma.
Upton A; Arvanitis TN
IEEE J Biomed Health Inform; 2014 May; 18(3):810-6. PubMed ID: 24058043
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA profiling of Chinese primary glioblastoma reveals a temozolomide-chemoresistant subtype.
Yan W; Liu Y; Yang P; Wang Z; You Y; Jiang T
Oncotarget; 2015 May; 6(13):11676-82. PubMed ID: 25869098
[TBL] [Abstract][Full Text] [Related]
37. Integration of RNA-Seq and proteomics data identifies glioblastoma multiforme surfaceome signature.
Syafruddin SE; Nazarie WFWM; Moidu NA; Soon BH; Mohtar MA
BMC Cancer; 2021 Jul; 21(1):850. PubMed ID: 34301218
[TBL] [Abstract][Full Text] [Related]
38. A long non-coding RNA signature in glioblastoma multiforme predicts survival.
Zhang XQ; Sun S; Lam KF; Kiang KM; Pu JK; Ho AS; Lui WM; Fung CF; Wong TS; Leung GK
Neurobiol Dis; 2013 Oct; 58():123-31. PubMed ID: 23726844
[TBL] [Abstract][Full Text] [Related]
39. Integrated analysis of genome-wide DNA methylation, gene expression and protein expression profiles in molecular subtypes of WHO II-IV gliomas.
Wang ZL; Zhang CB; Cai JQ; Li QB; Wang Z; Jiang T
J Exp Clin Cancer Res; 2015 Oct; 34():127. PubMed ID: 26502731
[TBL] [Abstract][Full Text] [Related]
40. GTI: a novel algorithm for identifying outlier gene expression profiles from integrated microarray datasets.
Mpindi JP; Sara H; Haapa-Paananen S; Kilpinen S; Pisto T; Bucher E; Ojala K; Iljin K; Vainio P; Björkman M; Gupta S; Kohonen P; Nees M; Kallioniemi O
PLoS One; 2011 Feb; 6(2):e17259. PubMed ID: 21365010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]